For many Americans, a routine surgical procedure serves as their first introduction to opioid pain medication. While most stop using these drugs as they heal, a considerable number of "opioid-naïve" ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked. As GLP-1 medications continue to ...

Now that generative artificial intelligence tools have been widely implemented in retirement planning, experts suggest advisers turn to embedded AI to ramp up efficiency. Generative artificial ...

Research shows that practicing these two key sleep hygiene roles every night can help you live longer When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

Musk could be consolidating his companies. Musk could be consolidating his companies. is a senior reporter covering technology, gaming, and more. He joined The Verge in 2019 after nearly two years at ...

On the Wednesday, January 28, 2026, episode of The Excerpt podcast: As GLP-1 use surges, lawsuits allege blindness, stomach paralysis and more. USA TODAY Investigative Reporter Austin Fast breaks down ...

Netflix has confirmed plans ramp up AI use at the company, with plans to expand its tools for subtitle localization and advertisement creation for its subscribers in 2026. The streaming giant touched ...

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing appetites and nutrition needs. As GLP-1 medications normalize smaller ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...